Synairgen
Synairgen is a respiratory biotech company focused on developing inhaled interferon beta (IFN-?) for the treatment of severe viral lung infections. They are working on a host-directed, broad-spectrum antiviral treatment delivered directly into the lungs.
- Inhaled interferon beta (IFN-β)
- Broad-spectrum antiviral treatments
- Clinical trials for respiratory infections
Locations
Company Details
Synairgen is operated by Synairgen Limited and is a Active company incorporated on 16 September 2004 with the registered office located in Southampton, Hampshire. Synairgen Limited was registered 21 years ago.
Status
Active
Size
Small
Directors
12
Age
21 years old
Employees
34
Turnover
Unreported
Total Assets
£7.82M
Cash in Bank
£4.55M
Total Liabilities
-£1.54M